HomeCompareVBILX vs MRK

VBILX vs MRK: Dividend Comparison 2026

VBILX yields 4.13% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $30.6K in total portfolio value
10 years
VBILX
VBILX
● Live price
4.13%
Share price
$10.39
Annual div
$0.43
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.2K
Annual income
$538.55
Full VBILX calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — VBILX vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVBILXMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VBILX + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VBILX pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VBILX
Annual income on $10K today (after 15% tax)
$351.17/yr
After 10yr DRIP, annual income (after tax)
$457.77/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $7,870.64/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VBILX + MRK for your $10,000?

VBILX: 50%MRK: 50%
100% MRK50/50100% VBILX
Portfolio after 10yr
$41.5K
Annual income
$5,168.35/yr
Blended yield
12.46%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

VBILX
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VBILX buys
0
MRK buys
0
No recent congressional trades found for VBILX or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVBILXMRK
Forward yield4.13%2.76%
Annual dividend / share$0.43$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$26.2K$56.8K
Annual income after 10y$538.55$9,798.13
Total dividends collected$4.8K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: VBILX vs MRK ($10,000, DRIP)

YearVBILX PortfolioVBILX Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,113$413.14$11,206$366.19$93.00MRK
2$12,320$429.09$12,650$502.35$330.00MRK
3$13,627$444.57$14,407$694.19$780.00MRK
4$15,041$459.57$16,585$967.82$1.5KMRK
5$16,567$474.05$19,342$1,363.89$2.8KMRK
6$18,215$488.01$22,913$1,947.19$4.7KMRK
7$19,992$501.45$27,662$2,823.89$7.7KMRK
8$21,906$514.35$34,159$4,173.35$12.3KMRK
9$23,966$526.72$43,337$6,308.80$19.4KMRK
10$26,182$538.55$56,776$9,798.13$30.6KMRK

VBILX vs MRK: Complete Analysis 2026

VBILXStock

This index fund offers a low-cost, diversified approach to bond investing, providing broad exposure to U.S. investment-grade bonds with maturities from five to ten years. Reflecting this goal, the fund invests about 50% of assets in corporate bonds and 50% in U.S. government bonds within that maturity range. Risks of the fund include the fact that changes in interest rates, both up and down, can affect the fund by resulting in lower bond prices or an eventual decrease in income for the fund. Investors looking to add a diversified bond fund to their portfolio may wish to consider this fund.

Full VBILX Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this VBILX vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VBILX vs SCHDVBILX vs JEPIVBILX vs OVBILX vs KOVBILX vs MAINVBILX vs JNJVBILX vs ABBVVBILX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.